NCT04980690View on ClinicalTrials.gov

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Advanced Malignant Tumors
Interventions
BIOLOGICAL

IBC0966

IBC0966 is an investigational product.

Trial Locations (1)

150081

RECRUITING

The Affiliated Tumor Hospital of Harbin Medical University, Harbin

All Listed Sponsors
lead

SUNHO（China）BioPharmaceutical CO., Ltd.

INDUSTRY